Myricetin 3-O-galactoside tamide DiFi humancolon cancer cells andMDA

DiFi humancolon cancer cells andMDA MB-468 human breast cancer cells

NK-252 is a potential Nrf2 activator

5-benzothiazepin-8-yl]oxy}acetamido)-2-phenylacetamido]acetic acid

as modulators for apoptosis

Smiles: [2H]C([2H])([2H])C(O)([C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(/CCC[C@@]21C)=C/C=C1/C[C@@H](O)C[C@H](O)C/1=C)C([2H])([2H])[2H]

Myricetin 3-O-galactoside tamide DiFi humancolon cancer cells andMDAMyricetin 3 O galactoside inhibits xanthine oxidase (XO) activity, lipid peroxidation and scavenges the free radical. Myricetin 3 O galactoside inhibits lipid peroxidation with an IC50 of 160 g mL. Antioxidant activity. Product information CAS Number: 15648 86 9 Molecular Weight: 480. 38 Formula: C21H20O13 Chemical Name: 5,7 dihydroxy 3 {[(2S,3R,4S,5R,6R) 3,4,5 trihydroxy 6 (hydroxymethyl)oxan 2 yl]oxy} 2 (3,4,5 trihydroxyphenyl) 4H chromen 4 one